5 Multiple Myeloma Clinical Trials in Augusta, GA (2026)

Q: How do I join a clinical trial in Augusta?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Augusta research site will contact you.

Recruiting Multiple Myeloma Studies in Augusta

NCT02735707Recruiting

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

REMAP-CAP is a randomised, embedded, multifactorial, adaptive platform trial for community-acquired pneumonia. The purpose of this study is to evaluate the effect of a range of interventions to impro...

Augusta, GAPHASE320,000 participantsUMC Utrecht

View Study Details

NCT05722938Recruiting

Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)

The main objective of the trial is to assess the efficacy and safety of trimodulin as adjunctive treatment to standard of care (SoC) compared to placebo plus SoC in adult hospitalized subjects with sC...

Augusta, GAPHASE3590 participantsBiotest

View Study Details

NCT06588413Recruiting

Olanzapine 2.5 vs 5 mg in Quadruplet Nausea/Vomiting Prophylaxis Before High-Dose Melphalan

Patients who receive a chemotherapy called melphalan are at high risk of having nausea and vomiting. A medication called olanzapine has been shown to decrease nausea and vomiting after chemotherapy. A...

Augusta, GAPHASE3172 participantsAugusta University

View Study Details

NCT05846880Recruiting

VitD3 Supplementation in Patients With Multiple Myeloma

The goal of this clinical trial is to evaluate post-transplant immune reconstitution and lymphocyte recovery as well as the 3-year progression-free survival of patients with multiple myeloma in two tr...

Augusta, GAEARLY_PHASE1100 participantsAmany Keruakous, MD, MS.

View Study Details

NCT06142396Recruiting

Pilot Study Dara-CyBorD in Newly Diagnosed Multiple Myeloma Patients With Renal Failure

The goal of this study is to assess the efficacy of induction treatment with daratumumab-hyaluronidase (dara SC) with cyclophosphamide, bortezomib, and dexamethasone (Dara-CyBorD) for four cycles in p...

Augusta, GAEARLY_PHASE130 participantsAugusta University

View Study Details

About Multiple Myeloma Clinical Trials in Augusta

Multiple myeloma is a cancer of plasma cells in the bone marrow that produce abnormal antibodies. It can cause bone damage, kidney problems, and immune deficiency. Treatments have advanced significantly with proteasome inhibitors, immunomodulatory drugs, and CAR-T cell therapy.

There are currently 5 multiple myeloma clinical trials recruiting participants in Augusta, GA. These studies are seeking a combined 20,892 participants. Research is being sponsored by UMC Utrecht, Biotest, Augusta University and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Multiple Myeloma Clinical Trials in Augusta — FAQ

Are there multiple myeloma clinical trials in Augusta?

Yes, there are 5 multiple myeloma clinical trials currently recruiting in Augusta, GA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Augusta?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Augusta research site will contact you about next steps.

Are clinical trials in Augusta free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Augusta studies also compensate for your time and travel.

What multiple myeloma treatments are being tested?

The 5 active trials in Augusta are testing new therapies including novel drugs, biologics, and treatment approaches for multiple myeloma.

Data updated July 21, 2026 from ClinicalTrials.gov